Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluval AB Influenza Vaccine Serologic Trial in Healthy Adults
2004-001600-12Phase 4Completed
- Sponsor
- Omninvest
- Start
- Jul 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Fluval AB vaccine in influenza, sponsored by Omninvest. Primary endpoints: Seroconversion ratio and Increase in geometric mean titer. Started Jul 2004; status: completed.
02
Drugs
Fluval AB vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2004-001600-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001600-12.